Terms: = Testicular cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
2 results:
1. A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer.
Metzger E; Müller JM; Ferrari S; Buettner R; Schüle R
EMBO J; 2003 Jan; 22(2):270-80. PubMed ID: 12514133
[TBL] [Abstract] [Full Text] [Related]
2. Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase (review).
Chang NS
Int J Mol Med; 1998 Dec; 2(6):653-9. PubMed ID: 9850732
[TBL] [Abstract] [Full Text] [Related]
